Information  X 
Enter a valid email address

OxfCannabiTechHldgPlc OGbp0.01 (OCTP)

Date Time Source Announcement
16 May 2022 7:00 am
RNS
New Broker and Investor Presentation
25 Apr 2022 7:00 am
RNS
Formation of Scientific Advisory Board
06 Apr 2022 12:58 pm
RNS
Results of Requisitioned General Meeting
01 Apr 2022 7:00 am
RNS
Registered Office Address Change
31 Mar 2022 7:00 am
RNS
Updates on Lead Programme 1 and Programme 2
10 Mar 2022 11:34 am
RNS
Holding in Company
08 Mar 2022 8:26 pm
EQS
Data from pre-clinical study of OCT461201 shows positive results
  7:00 am
RNS
Data from pre-clinical study show positive results
04 Mar 2022 1:00 pm
RNS
Requisition of General Meeting - Update
03 Mar 2022 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
22 Feb 2022 7:00 am
RNS
Interim Results: 6 months to 30 November 2021
18 Feb 2022 5:15 pm
RNS
Requisition of General Meeting
07 Feb 2022 7:00 am
RNS
Notice of Interim Results & Investor Presentations
31 Jan 2022 7:00 am
RNS
Board Changes
24 Jan 2022 4:36 pm
RNS
Price Monitoring Extension
18 Jan 2022 7:00 am
RNS
Trading Update & Change of Accounting Year-End
07 Jan 2022 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
15 Dec 2021 2:06 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
02 Dec 2021 2:11 pm
RNS
Holding in Company
  2:09 pm
RNS
Holding in Company
  7:00 am
RNS
Director Dealings
01 Dec 2021 7:00 am
RNS
Admission to Trading on the US OTC QB Market
30 Nov 2021 5:00 pm
RNS
Corporate Adviser Change
29 Nov 2021 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
24 Nov 2021 5:06 pm
RNS
Directorate Change
  3:35 pm
RNS
Result of AGM
23 Nov 2021 7:00 am
RNS
New Agreement with Dalriada Drug Discovery Inc.
17 Nov 2021 7:00 am
RNS
New Agreement signed with Oxford Stemtech Limited
11 Nov 2021 7:00 am
RNS
Director Dealing Update
05 Nov 2021 1:35 pm
RNS
Director Dealing Update & Board Changes
01 Nov 2021 7:00 am
RNS
Director Dealing
27 Oct 2021 7:00 am
RNS
Posting of Annual Report & Notice of AGM
26 Oct 2021 7:00 am
RNS
Appointment of North American IR Adviser
13 Oct 2021 7:00 am
RNS
2021 Final Results and Notice of AGM
11 Oct 2021 7:00 am
RNS
New Partnerships Targeting Trigeminal Neuralgia
23 Sep 2021 4:21 pm
RNS
Rescheduling of Final Results Announcement
22 Sep 2021 7:00 am
RNS
Exclusive Agreement with Canopy Growth Corporation
23 Aug 2021 7:00 am
RNS
Pre-Close Trading Update & Notice of Final Results
28 Jul 2021 7:00 am
RNS
Post IPO Review & Notice of Trading Update
06 Jul 2021 7:00 am
RNS
Service Agreement with Drug Development Company
25 Jun 2021 8:14 am
RNS
Holding(s) in Company
04 Jun 2021 3:33 pm
RNS
Holding(s) in Company
  3:20 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Company Presentation Webinar to Retail Investors
01 Jun 2021 7:00 am
RNS
Consultancy Agreement with Voisin Consulting SARL
28 May 2021 7:00 am
RNS
Total Voting Rights
25 May 2021 10:13 am
RNS
Holding(s) in Company
  9:05 am
RNS
Holding(s) in Company
24 May 2021 5:32 pm
RNS
Holding(s) in Company
21 May 2021 7:00 am
RNS
Admission to Trading and First Day of Dealings

a d v e r t i s e m e n t